Acurx Pharmaceuticals Inc

NASDAQ:ACXP   3:23:50 PM EDT
3.18
+0.15 (+4.95%)
Earnings Announcements

Acurx Pharmaceuticals Inc Reports Third Quarter 2022 Results And Provides Business Update

Published: 11/14/2022 13:30 GMT
Acurx Pharmaceuticals Inc (ACXP) - Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update.
Acurx Pharmaceuticals Inc - Reported a Net Loss of $3.5 Million Or $0.32 per Diluted Share for Three Months Ended September 30, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.